Evidence map›Paper›PMID 38048258›Full record

ReviewACS applied bio materials2024

Magnetic Cellular Backpacks for Spatial Targeting, Imaging, and Immunotherapy.

Nicole B Day, Christopher R Orear, Ambar C Velazquez-Albino, Hayden J Good, Andrii Melnyk, Carlos M Rinaldi-Ramos, C Wyatt Shields Iv

Open access · greenAbstract readReview
In one paragraph

Review in ACS applied bio materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Transport of Adoptive Cell Transfers With Magnetic Helical Microrobots.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. [Biomaterials of different sizes for enhanced adoptive cell transfer therapy in solid tumors].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nicole B DayDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States.ORCID 0000-0003-1082-2887
Christopher R OrearBiomedical Engineering Program, University of Colorado Boulder, Boulder, Colorado 80303, United States.
Ambar C Velazquez-AlbinoDepartment of Chemical Engineering, University of Florida, Gainesville, Florida 32611, United States.ORCID 0009-0000-5901-4288
Hayden J GoodDepartment of Chemical Engineering, University of Florida, Gainesville, Florida 32611, United States.ORCID 0009-0001-5529-3109
Andrii MelnykDepartment of Chemical Engineering, University of Florida, Gainesville, Florida 32611, United States.ORCID 0000-0001-5823-5791
Carlos M Rinaldi-RamosDepartment of Chemical Engineering, University of Florida, Gainesville, Florida 32611, United States.ORCID 0000-0001-8886-5612
C Wyatt Shields IvDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States.ORCID 0000-0003-4138-8462
University of Florida · USUniversity of Colorado Boulder · US

Funding

Predoctoral Training Molecular BiophysicsT32GM065103 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2002 to 2021
$4.3M
Interdisciplinary Predoctoral Training in Molecular BiophysicsT32GM145437 · NIGMS · UNIVERSITY OF COLORADO · PI JOSEPH J FALKE · 2022 to 2026
$2.5M
NIH Administrative Supplement to Promote Diversity in Health Related ResearchR01EB031224 · NIBIB · UNIVERSITY OF FLORIDA · PI RINALDI-RAMOS, CARLOS M · 2022 to 2025
$2.4M
Adoptive Macrophage Transfers for Nanoparticle DeliveryR35GM147455 · NIGMS · UNIVERSITY OF COLORADO · PI Charles Wyatt Shields IV · 2022 to 2026
$2.0M
FACSAria Fusion Cell SorterS10OD021601 · OD · UNIVERSITY OF COLORADO · PI LIU, XUEDONG · 2016 to 2016
$599k
Macrophage-Mediated Delivery of Acoustically Propelled Nanoparticles for Sensitizing Immunologically Cold TumorsR21CA267608 · NCI · UNIVERSITY OF COLORADO · PI GOODWIN, ANDREW P, SHIELDS IV, CHARLES WYATT · 2022 to 2023
$381k
NCI NIH HHS R21 CA267608NIBIB NIH HHS R01 EB031224NIGMS NIH HHS R35 GM147455NIGMS NIH HHS T32 GM065103NIGMS NIH HHS T32 GM145437NIH HHS S10 OD021601
6 · The paper itself

Abstract

Adoptive cell transfer (ACT) therapies are growing in popularity due to their ability to interact with diseased tissues in a specific manner. Disc-shaped particles, or "backpacks", that bind to cellular surfaces show promise for augmenting the therapeutic potential of adoptively transferred cells by resisting phagocytosis and locally releasing drugs to maintain cellular activity over time. However, many ACTs suffer from limited tumor infiltration and retention and lack a method for real-time spatial analysis. Therefore, we have designed biodegradable backpacks loaded with superparamagnetic iron oxide nanoparticles (SPIONs) to improve upon current ACT strategies by (i) controlling the localization of cell-backpack complexes using gradient magnetic fields and (ii) enabling magnetic particle imaging (MPI) to track complexes after injection. We show that magnetic backpacks bound to macrophages and loaded with a proinflammatory drug, resiquimod, maintain anticancer phenotypes of carrier macrophages for 5 days and create cytokine "factories" that continuously release IL-12. Furthermore, we establish that forces generated by gradient magnet fields are sufficient to displace cell-backpack complexes in physiological settings. Finally, we demonstrate that MPI can be used to visualize cell-backpack complexes in mouse tumors, enabling a potential strategy to track the biodistribution of ACTs in real time.

Indexed as

ImmunotherapyAnimalsBiocompatible MaterialsMacrophagesMagnetic Iron Oxide NanoparticlesMagnetite NanoparticlesMaterials TestingMiceParticle SizeBiocompatible MaterialsMagnetite Nanoparticlesadoptive cell transfercancerdrug deliveryimmunotherapymacrophagemagnetic particle imagingmicroparticle

Identifiers

PMID38048258
PMCPMC11147956
OpenAlexW4389306382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.